Abstract
The objective was to investigate the predictive factors for avascular necrosis (AVN) of bone in patients with systemic lupus erythematosus (SLE). The records of 868 patients with SLE from four centers were reviewed retrospectively. Forty-nine patients with AVN were identified. A total of 154 patients with SLE who did not have clinically apparent AVN during the follow-up were evaluated as a control group. The demographic, clinical, laboratory and management characteristics of these two groups of patients were recorded according to predefined protocol and compared. The prevalence of AVN was detected 6% in our SLE population. The highest dose corticosteroid administered within 4 months and total cumulative prednisolone dose were significantly higher in the SLE patients with AVN. The use of cytotoxic agent significantly higher proportion of patients with AVN. AVN tends to develop more frequently in male gender and younger patients. Oral ulcer, pleuritis, Raynaud’s phenomenon, cutaneous vasculitis, lymphadenopathy, autoimmune thyroiditis, peripheral neuropathy and Sjögren’s syndrome were higher incidence in SLE patients with AVN. The bilateral femoral heads were the commonest site of involvement of AVN in our patients with SLE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abu-Shakra M, Buskila D, Shoenfeld Y (2003) Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 25:13–24
Petri M (1995) Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8:137–145
Gladman DD, Chaudhry-Ahluwalia V, Ibañez D, Bogoch E, Urowitz MB (2001) Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol 28:2226–2229
Dimant J, Ginzler EM, Diamond HS, Schlesinger M, Marino CT, Weiner M, Kaplan D (1978) Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 5:136–141
Smith FE, Sweet DE, Brunner CM, Davis JS 4th (1976) Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis 35:227–232
Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB (1985) Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79:596–604
Klipper AR, Stevens MB, Zizic TM, Hungerford DS (1976) Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 55:251–257
Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M (1997) Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24:654–662
Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ (2001) Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 28:761–765
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Nagasawa K, Ishii Y, Mayumi T, Tada Y, Ueda A, Yamauchi Y et al (1989) Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 48:672–676
Mok CC, Lau CS, Wong RW (1998) Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37:895–900
Mok MY, Farewell VT, Isenberg DA (2000) Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis 59:462–467
Leventhal GH, Dorfman HD (1974) Aseptic necrosis of bone in systemic lupus erythematosus. Semin Arthritis Rheum 4:73–93
Velayos EE, Leidholt JD, Smyth JC, Priest R (1966) Arthropathy associated with steroid therapy. Ann Intern Med 64:759–771
Calvo-Alen J, McGwin G, Toloza S, Fernandez M, Roseman JM, Bastian HM et al (2006) Systemic Lupus Erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis 65:785–790
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311
Asherson RA, Lioté F, Page B, Meyer O, Buchanan N, Khamashta MA et al (1993) Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20:284–288
Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM (2003) Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 48:732–736
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sayarlioglu, M., Yuzbasioglu, N., Inanc, M. et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int 32, 177–182 (2012). https://doi.org/10.1007/s00296-010-1597-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1597-9